Loading...
•
Jun 30, 2021
LeMaitre Vascular Q2 2021 Earnings Report
LeMaitre Vascular's Q2 2021 results were reported, showcasing significant growth driven by strategic acquisitions and operational efficiencies.
Key Takeaways
LeMaitre Vascular reported a strong Q2 2021 with a 64% increase in sales, reaching $40.7 million, and a 128% increase in operating income to $11.1 million. Net income increased by 137% to $8.3 million, with earnings per share at $0.40, a 131% increase. The company also announced a quarterly dividend of $0.11 per share.
Sales increased by 64% to $40.7 million, with organic growth of 35% compared to Q2 2020.
Operating income rose by 128% to $11.1 million, driven partially by the Artegraft acquisition.
Net income increased by 137% to $8.3 million, with earnings per diluted share at $0.40.
The company completed a $54.5 million follow-on public stock offering, using $23.0 million to repay long-term debt.
Forward Guidance
LeMaitre provided financial outlook with sales guidance between $38.3 million and $40.3 million, and EPS guidance between $0.30 and $0.35 for the next quarter.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...